Author: John Richards | Practices: , , | Tags: , , , , , , , , , , ,

American Axle v. Neapco

Introduction On July 31, 2020, in American Axle v. Neapco, the Federal Circuit split 6-6 on the question of whether to grant en banc review of a panel decision on patent eligibility seen by many as an unwarranted extension of the principle that...

Read Article

Author: John Richards | Practices: , | Tags: , , , , , , ,

THRYV INC. v. CLICK-TO-CALL TECHNOLOGIES LP

The question of whether the United States Court of Appeals for the Federal Circuit Court of Appeals has any right to examine a decision of the Patent Trial and Appeal Board (PTAB) to institute inter partes review or post grant review, as opposed to...

Read Article

Author: Marisa Masters (L&P Intern) | Co-Author: Robert Peverada | Practices: , | Tags: , , ,

REMEMBERING TWO OF THE SPOOKIEST HALLOWEEN COPYRIGHT CASES

With Halloween 2020 approaching, we thought it was important to remember two of the spookiest of intellectual property cases, in particular, those copyright cases addressing issues with well-known horror movies. GALLAGHER v. LIONS GATE...

Read Article

Author: John Richards | Practices: , , | Tags: , , , , , , ,

DESIGN PATENT PROTECTION FOR REPLACEMENT PARTS

The fight between insurers and car manufacturers as to whether and, if so how, to protect the design of spare parts for cars delayed the implementation of an EU regulation on design protection for well over a decade and ended in an uneasy...

Read Article

Author: Ralph H. Cathcart | Practices: , | Tags: , , , ,

DIVERSITY IN INTELLECTUAL PROPERTY

Ladas & Parry LLP considers diversity and inclusion as core values and principles that provide access to opportunity and ensure excellence, particularly in the IP field. We salute those who have helped shape the world and would like to shine a...

Read Article

Author: John Richards | Practices: , | Tags: , , , ,

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc: Prior Public Sale may destroy novelty without disclosure of inventive feature

In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc, the United States Supreme Court held that a prior public sale of a patented product could destroy the novelty of a patent for that product even though there was no disclosure of the...

Read Article